Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shilpa Grover, M.D.

Co-Author

This page shows the publications co-authored by Shilpa Grover and Osama Rahma.
Connection Strength

3.210
  1. Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis. Cancer. 2020 08 15; 126(16):3758-3767.
    View in: PubMed
    Score: 0.880
  2. Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis. JCO Oncol Pract. 2020 09; 16(9):e933-e942.
    View in: PubMed
    Score: 0.874
  3. Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitis. Hepatology. 2022 03; 75(3):531-540.
    View in: PubMed
    Score: 0.243
  4. Correction to: Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series. Dig Dis Sci. 2021 Aug; 66(8):2843-2844.
    View in: PubMed
    Score: 0.238
  5. Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis. Cancer. 2020 12 01; 126(23):5088-5097.
    View in: PubMed
    Score: 0.223
  6. Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series. Dig Dis Sci. 2021 06; 66(6):1974-1980.
    View in: PubMed
    Score: 0.222
  7. Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service. J Immunother Cancer. 2020 08; 8(2).
    View in: PubMed
    Score: 0.222
  8. Gastrointestinal and Hepatic Toxicities of Checkpoint Inhibitors: Algorithms for Management. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:13-19.
    View in: PubMed
    Score: 0.190
  9. Utility of Liver Biopsy in Diagnosis and Management of High-grade Immune Checkpoint Inhibitor Hepatitis in Patients With Cancer. JAMA Oncol. 2021 11 01; 7(11):1711-1714.
    View in: PubMed
    Score: 0.060
  10. Medication-specific variations in morphological patterns of injury in immune check-point inhibitor-associated colitis. Histopathology. 2021 Mar; 78(4):532-541.
    View in: PubMed
    Score: 0.057
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.